Skip to content
healthcare.dev
Get a free key

NATEGLINIDE

NDC 16571-759, NATEGLINIDE, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-759
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205544
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-759 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NATEGLINIDE120 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
16571-759-0116571075901100 TABLET in 1 BOTTLE (16571-759-01)
16571-759-091657107590990 TABLET in 1 BOTTLE (16571-759-09)
16571-759-5016571075950500 TABLET in 1 BOTTLE (16571-759-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b41f4180-96a7-411d-b827-5021e534f556

  • NADAC price for package 16571075909

    GET /v1/drugs/nadac/16571075909

Use it

Look up 16571-759 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-759 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-759. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.